APH — Alliance Pharma Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for Alliance Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	118	136	130	163	167
Cost of Revenue
Gross Profit	72.6	86.1	82.8	109	102
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	92.6	100	113	142	157
Operating Profit	25.6	35.6	16.3	21.6	10.6
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	22.8	31.1	13	18.2	5.21
Provision for Income Taxes
Net Income After Taxes	18.4	25	8.03	7.32	0.936
Net Income Before Extraordinary Items
Net Income	18.4	25	8.03	7.32	0.936
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	18.4	25	8.03	7.32	0.936
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.048	0.052	0.043	0.025	0.04
Dividends per Share